Buchanan Life Sciences Team Closes a 9-Figure Cross-Border Transaction

Newark, New Jersey (February 2026) - A Buchanan Life Sciences team, comprised of Dae Lee, Tina Hu-Rodgers, Haley Ayure, Richard Montes de Oca and Jordan Yeagley, successfully closed a 9-figure investment transaction on behalf of a U.S.-based client funded by a foreign investor, with an additional 9-figure tranche available under a structured option. 

This cross-border transaction of meaningful size and complexity required careful coordination across legal, regulatory and commercial fronts. The team led a comprehensive due diligence process to ensure the transaction complied with all applicable federal and state laws, including regulatory, corporate governance and industry-specific requirements. They evaluated the ownership structure, capital flows, regulatory exposure, and compliance risk, and conducted in-depth due diligence to help protect the investment against any scrutiny at the time of closing and well beyond. 

In parallel, the team negotiated and drafted the definitive transaction documents that memorialize the full scope of the investment, including governance rights, capital deployment terms, protective provisions, and the mechanics of the additional 9-figure investment option. The team provided the client with flexibility in how they operate, while also ensuring every detail was compliant and protected against potential regulatory or control issues that can arise with foreign investments.

The transaction will allow the client to accelerate strategic growth, strengthen its balance sheet, expand operations domestically and invest in long-term structure without compromising control or governance discipline. More importantly, this capital positions the client to compete at a different level.  In today’s market, scale, compliance sophistication, and access to patient capital separate market leaders from everyone else. A properly structured 9-figure investment does not just fund expansion but, rather, creates stability, leverage and strategic optionality.  

From an industry standpoint, transactions of this magnitude signal confidence in the sector and reinforce that disciplined operators with a strong regulatory footing continue to attract serious global capital.